BioVie Inc.
BIVI
$1.88
-$0.03-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.13% | 0.90% | -0.84% | -21.81% | -23.39% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.86% | -49.97% | -46.10% | -46.04% | -28.62% |
| Operating Income | 43.86% | 49.97% | 46.10% | 46.04% | 28.62% |
| Income Before Tax | 45.39% | 47.66% | 43.90% | 49.43% | 36.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.39% | 47.66% | 43.90% | 49.43% | 36.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.39% | 47.66% | 43.90% | 49.43% | 36.09% |
| EBIT | 43.86% | 49.97% | 46.10% | 46.04% | 28.62% |
| EBITDA | 44.17% | 50.27% | 46.34% | 46.27% | 28.76% |
| EPS Basic | 81.15% | 78.04% | 66.67% | 61.22% | 49.30% |
| Normalized Basic EPS | 81.36% | 78.15% | 68.78% | 62.91% | 50.57% |
| EPS Diluted | 81.10% | 78.00% | 66.74% | 61.33% | 49.40% |
| Normalized Diluted EPS | 81.36% | 78.15% | 68.78% | 62.91% | 50.57% |
| Average Basic Shares Outstanding | 227.43% | 199.64% | 123.26% | 49.16% | 39.10% |
| Average Diluted Shares Outstanding | 227.43% | 199.64% | 123.26% | 49.16% | 39.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |